One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of p501s prostate specific marker, also known as prostein, in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of p501s prostate specific marker, also known as prostein, in a clinical specimen using an enzyme immunohistochemistry method.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of p501s prostate specific marker, also known as prostein, in a clinical specimen.